Serine/Threonine Phosphatases in Atrial Fibrillation
- PMID: 28077320
- PMCID: PMC5346472
- DOI: 10.1016/j.yjmcc.2016.12.009
Serine/Threonine Phosphatases in Atrial Fibrillation
Abstract
Serine/threonine protein phosphatases control dephosphorylation of numerous cardiac proteins, including a variety of ion channels and calcium-handling proteins, thereby providing precise post-translational regulation of cardiac electrophysiology and function. Accordingly, dysfunction of this regulation can contribute to the initiation, maintenance and progression of cardiac arrhythmias. Atrial fibrillation (AF) is the most common heart rhythm disorder and is characterized by electrical, autonomic, calcium-handling, contractile, and structural remodeling, which include, among other things, changes in the phosphorylation status of a wide range of proteins. Here, we review AF-associated alterations in the phosphorylation of atrial ion channels, calcium-handling and contractile proteins, and their role in AF-pathophysiology. We highlight the mechanisms controlling the phosphorylation of these proteins and focus on the role of altered dephosphorylation via local type-1, type-2A and type-2B phosphatases (PP1, PP2A, and PP2B, also known as calcineurin, respectively). Finally, we discuss the challenges for phosphatase research, potential therapeutic significance of altered phosphatase-mediated protein dephosphorylation in AF, as well as future directions.
Keywords: atrial fibrillation; calcium handling; ion channels; myofilaments; protein phosphatases.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
X.H.T.W. is a founding partner of Elex Biotech, a start-up company that developed drug molecules that target ryanodine receptors for the treatment of cardiac arrhythmia disorders. D.D. is consultant for OMEICOS Therapeutics that develops drug molecules targeting the ω-fatty acid metabolism as an antiarrhythmic therapeutic strategy. J.H. and S.G declared no conflicts of interest.
Figures



Similar articles
-
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.Circulation. 2006 Aug 15;114(7):670-80. doi: 10.1161/CIRCULATIONAHA.106.636845. Epub 2006 Aug 7. Circulation. 2006. PMID: 16894034
-
Function and regulation of serine/threonine phosphatases in the healthy and diseased heart.J Mol Cell Cardiol. 2013 Nov;64:90-8. doi: 10.1016/j.yjmcc.2013.09.006. Epub 2013 Sep 16. J Mol Cell Cardiol. 2013. PMID: 24051368 Review.
-
Function and regulation of phosphatase 1 in healthy and diseased heart.Cell Signal. 2022 Feb;90:110203. doi: 10.1016/j.cellsig.2021.110203. Epub 2021 Nov 22. Cell Signal. 2022. PMID: 34822978 Review.
-
Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. role of phosphatase 2A.Cardiovasc Res. 2003 Jul 1;59(1):37-45. doi: 10.1016/s0008-6363(03)00357-2. Cardiovasc Res. 2003. PMID: 12829174
-
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.J Mol Cell Cardiol. 2009 Mar;46(3):385-94. doi: 10.1016/j.yjmcc.2008.11.012. Epub 2008 Nov 27. J Mol Cell Cardiol. 2009. PMID: 19100271
Cited by
-
Deletion of Pr72 causes cardiac developmental defects in Zebrafish.PLoS One. 2018 Nov 27;13(11):e0206883. doi: 10.1371/journal.pone.0206883. eCollection 2018. PLoS One. 2018. PMID: 30481179 Free PMC article.
-
Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.Cell Signal. 2021 Oct;86:110070. doi: 10.1016/j.cellsig.2021.110070. Epub 2021 Jul 2. Cell Signal. 2021. PMID: 34217833 Free PMC article. Review.
-
Hypoxia modulates protein phosphatase 2A through HIF-1α dependent and independent mechanisms in human aortic smooth muscle cells and ventricular cardiomyocytes.Br J Pharmacol. 2019 Jun;176(11):1745-1763. doi: 10.1111/bph.14648. Epub 2019 Apr 22. Br J Pharmacol. 2019. PMID: 30825189 Free PMC article.
-
Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation.Clin Cardiol. 2020 Dec;43(12):1450-1459. doi: 10.1002/clc.23461. Epub 2020 Sep 17. Clin Cardiol. 2020. PMID: 32940379 Free PMC article.
-
Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis.Cardiovasc Res. 2023 Oct 24;119(13):2294-2311. doi: 10.1093/cvr/cvad118. Cardiovasc Res. 2023. PMID: 37523735 Free PMC article.
References
-
- Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453–1468. - PubMed
-
- Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014;114:1483–1499. - PubMed
-
- Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical